Literature DB >> 12791093

On the site of C4 deposition upon complement activation via the mannan-binding lectin pathway or the classical pathway.

M Møller-Kristensen1, S Thiel, A G Hansen, J C Jensenius.   

Abstract

The mannan-binding lectin (MBL) pathway and the classical pathway of complement activation are initiated by the binding of the recognition structure of the initiator complexes, MBL and C1q, respectively, to their ligands, i.e. carbohydrate structures or immune complexes. Proenzymes associated with MBL or C1q are then activated and generate C3 convertase through the activation of C4 and C2. The cleavage product of C4, C4b, attaches covalently to nearby hydroxyl or amino groups. The current picture is that C2 must then attach to C4b before being cleaved by the same associated proteases into the enzymatically active fragment, C2b. This suggests a stringent requirement for the deposition of C4b very close to the initiator complex, or indeed onto the initiator complex. We examined the possibility of C4b being bound to the initiator complex by a solid-phase assay, allowing for the selective elution of the initiator complexes, followed by quantification of the C4b being eluted and the C4b remaining on the solid phase. Also, we estimated the generation of complexes between the released initiator complex and C4b. More than 99% of deposited C4b was bound directly to the solid phase rather than to the initiator complex. Our approach cannot answer the question of the whereabouts of the C2 when it is cleaved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791093     DOI: 10.1046/j.1365-3083.2003.01270.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  6 in total

1.  Investigating the humoral immune response in chronic venous leg ulcer patients colonised with Pseudomonas aeruginosa.

Authors:  Jasper N Jacobsen; Anders S Andersen; Michael K Sonnested; Inga Laursen; Bo Jorgensen; Karen A Krogfelt
Journal:  Int Wound J       Date:  2010-11-19       Impact factor: 3.315

2.  Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1-associated membranous nephropathy.

Authors:  George Haddad; Johan M Lorenzen; Hong Ma; Noortje de Haan; Harald Seeger; Christelle Zaghrini; Simone Brandt; Malte Kölling; Urs Wegmann; Bence Kiss; Gábor Pál; Péter Gál; Rudolf P Wüthrich; Manfred Wuhrer; Laurence H Beck; David J Salant; Gérard Lambeau; Andreas D Kistler
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

3.  C-reactive protein collaborates with plasma lectins to boost immune response against bacteria.

Authors:  Patricia M L Ng; Agnès Le Saux; Chia M Lee; Nguan S Tan; Jinhua Lu; Steffen Thiel; Bow Ho; Jeak L Ding
Journal:  EMBO J       Date:  2007-06-21       Impact factor: 11.598

4.  Flexibility in Mannan-Binding Lectin-Associated Serine Proteases-1 and -2 Provides Insight on Lectin Pathway Activation.

Authors:  Ruodan Nan; Christopher M Furze; David W Wright; Jayesh Gor; Russell Wallis; Stephen J Perkins
Journal:  Structure       Date:  2017-01-19       Impact factor: 5.006

Review 5.  Nanobodies Provide Insight into the Molecular Mechanisms of the Complement Cascade and Offer New Therapeutic Strategies.

Authors:  Alessandra Zarantonello; Henrik Pedersen; Nick S Laursen; Gregers R Andersen
Journal:  Biomolecules       Date:  2021-02-17

Review 6.  Paths reunited: Initiation of the classical and lectin pathways of complement activation.

Authors:  Russell Wallis; Daniel A Mitchell; Ralf Schmid; Wilhelm J Schwaeble; Anthony H Keeble
Journal:  Immunobiology       Date:  2009-09-27       Impact factor: 3.144

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.